1. Recent Funding
2. Investors
3. Eli Lilly and Company

Eli Lilly and Company has backed 2 companies on Recent Funding, 2 in the last 12 months; its most recent deal is AdvanCell (2026-07-15).

What Eli Lilly and Company invests in

• Health and bio · 2 · 100%
• Education · 1 · 50%

How Eli Lilly and Company invests

Share is of the 2 rounds on Recent Funding that name Eli Lilly and Company. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with Eli Lilly and Company	Total raised	Latest raise
AAdvanCell Health and bio	Jul 15, 2026 Series b+ · $315M	$439.5M	Jul 15, 2026 Series b+
NNewLimit Health and bio	Oct 20, 2025 Series b+ · $45M	$650M	Jun 2, 2026 Series b+

Most frequent co-investors

• CCatalio1 shared round · last Jul 15, 2026
• FFidelity Management & Research Company1 shared round · last Jul 15, 2026
• TT. Rowe Price1 shared round · last Jul 15, 2026
• MMorningside1 shared round · last Jul 15, 2026
• SSV Health Investors1 shared round · last Jul 15, 2026
• SSanofi Ventures1 shared round · last Jul 15, 2026
• AAbingworth1 shared round · last Jul 15, 2026
• SSymBiosis1 shared round · last Jul 15, 2026
• TTenmile1 shared round · last Jul 15, 2026
• BBrandon Capital1 shared round · last Jul 15, 2026
• AAlly Bridge Group1 shared round · last Jul 15, 2026
• AAlpha Wave1 shared round · last Jul 15, 2026

Portfolio companies are the companies on Recent Funding with a round that lists Eli Lilly and Company, which is a subset of its real portfolio. API: /api/v1/investors/eli-lilly-and-company. All investors.